AAAAAA

   
Results: 1-13 |
Results: 13
The role of cytotoxic therapy with hematopoietic stem cell transplantationin the therapy of diffuse large cell B-Cell non-Hodgkin's lymphoma: An evidence-based review
Authors: Hahn, T Wolff, SN Czuczman, M Fisher, RI Lazarus, HM Vose, J Warren, L Watt, R McCarthy, PL
Citation: T. Hahn et al., The role of cytotoxic therapy with hematopoietic stem cell transplantationin the therapy of diffuse large cell B-Cell non-Hodgkin's lymphoma: An evidence-based review, BIOL BLOOD, 7(6), 2001, pp. 308-331
Age and cytogenetics as predictors of event free survival in patients withacute non-lymphocytic leukemia receiving high dose cytosine arabinoside and daunorubicin as consolidation chemotherapy
Authors: Stein, RS Wolff, SN Greer, JP Flexner, JM Goodman, S Jagasia, M Brandt, SJ Morgan, DS Arrowsmith, E McCurley, TL
Citation: Rs. Stein et al., Age and cytogenetics as predictors of event free survival in patients withacute non-lymphocytic leukemia receiving high dose cytosine arabinoside and daunorubicin as consolidation chemotherapy, LEUK LYMPH, 42(5), 2001, pp. 913-922
Intensified preparative regimens and allogeneic transplantation in refractory or relapsed intermediate and high grade non-Hodgkin's lymphoma
Authors: Stein, RS Greer, JP Goodman, S Brandt, SJ Morgan, D Macon, WR McCurley, TL Wolff, SN
Citation: Rs. Stein et al., Intensified preparative regimens and allogeneic transplantation in refractory or relapsed intermediate and high grade non-Hodgkin's lymphoma, LEUK LYMPH, 41(3-4), 2001, pp. 343-352
Is total body irradiation a necessary component of preparative therapy forautologous transplantation in non-Hodgkin's lymphoma
Authors: Stein, RS Greer, JP Goodman, S Brandt, SJ Morgan, DS Macon, WR McCurley, TL Wolff, SN
Citation: Rs. Stein et al., Is total body irradiation a necessary component of preparative therapy forautologous transplantation in non-Hodgkin's lymphoma, LEUK LYMPH, 41(1-2), 2001, pp. 97-103
Valacyclovir for the prevention of cytomegalovirus infection after allogeneic stem cell transplantation: a single institution retrospective cohort analysis
Authors: Vusirikala, M Wolff, SN Stein, RS Brandt, SJ Morgan, DS Greer, JP Schuening, FG Dummer, JS Goodman, SA
Citation: M. Vusirikala et al., Valacyclovir for the prevention of cytomegalovirus infection after allogeneic stem cell transplantation: a single institution retrospective cohort analysis, BONE MAR TR, 28(3), 2001, pp. 265-270
A multicenter, randomized, double-blind comparison of different doses of intravenous immunoglobulin for prevention of graft-versus-host disease and infection after allogeneic bone marrow transplantation
Authors: Winston, DJ Antin, JH Wolff, SN Bierer, BE Small, T Miller, KB Linker, C Kaizer, H Lazarus, HM Petersen, FB Cowan, MJ Ho, WG Wingard, JR Schiller, GJ Territo, MC Jiao, J Petrarca, MA Tonetta, SA
Citation: Dj. Winston et al., A multicenter, randomized, double-blind comparison of different doses of intravenous immunoglobulin for prevention of graft-versus-host disease and infection after allogeneic bone marrow transplantation, BONE MAR TR, 28(2), 2001, pp. 187-196
Recombinant human thrombopoietin (rhTPO) after autologous bone marrow transplantation: a phase I pharmacokinetic and pharmacodynamic study
Authors: Wolff, SN Herzig, R Lynch, J Ericson, SG Greer, JP Stein, R Goodman, S Benyunes, MC Ashby, M Jones, DV Fay, J
Citation: Sn. Wolff et al., Recombinant human thrombopoietin (rhTPO) after autologous bone marrow transplantation: a phase I pharmacokinetic and pharmacodynamic study, BONE MAR TR, 27(3), 2001, pp. 261-268
Fluconazole vs low-dose amphotericin B for the prevention of fungal infections in patients undergoing bone marrow transplantation: a study of the North American Marrow Transplant Group
Authors: Wolff, SN Fay, J Stevens, D Herzig, RH Pohlman, B Bolwell, B Lynch, J Ericson, S Freytes, CO LeMaistre, F Collins, R Pineiro, L Greer, J Stein, R Goodman, SA Dummer, S
Citation: Sn. Wolff et al., Fluconazole vs low-dose amphotericin B for the prevention of fungal infections in patients undergoing bone marrow transplantation: a study of the North American Marrow Transplant Group, BONE MAR TR, 25(8), 2000, pp. 853-859
Outcome of allogeneic stem cell transplantation for B cell chronic lymphocytic leukemia
Authors: Pavletic, ZS Arrowsmith, ER Bierman, PJ Goodman, SA Vose, JM Tarantolo, SR Stein, RS Bociek, G Greer, JP Wu, CD Kollath, JP Weisenburger, DD Kessinger, A Wolff, SN Armitage, JO Bishop, MR
Citation: Zs. Pavletic et al., Outcome of allogeneic stem cell transplantation for B cell chronic lymphocytic leukemia, BONE MAR TR, 25(7), 2000, pp. 717-722
Intensified preparative regimens and autologous transplantation in refractory or relapsed intermediate grade non-Hodgkin's lymphoma
Authors: Stein, RS Greer, JP Goodman, S Brandt, SJ Morgan, DS Macon, WR McCurley, TL Wolff, SN
Citation: Rs. Stein et al., Intensified preparative regimens and autologous transplantation in refractory or relapsed intermediate grade non-Hodgkin's lymphoma, BONE MAR TR, 25(3), 2000, pp. 257-262
Protracted results of dose-intensive therapy using cyclophosphamide, carmustine, and continuous infusion etoposide with autologous stem cell support in patients with relapse or refractory Hodgkin's disease: a phase II study from the north American marrow transplant group
Authors: Fleming, DR Wolff, SN Fay, JW Brown, RA Lynch, JP Bolwell, BJ Stevens, DA Goodman, SA Greer, JP Stein, RS Pineiro, LA Collins, RH Goldsmith, LJ Herzig, GP Herzig, RH
Citation: Dr. Fleming et al., Protracted results of dose-intensive therapy using cyclophosphamide, carmustine, and continuous infusion etoposide with autologous stem cell support in patients with relapse or refractory Hodgkin's disease: a phase II study from the north American marrow transplant group, LEUK LYMPH, 35(1-2), 1999, pp. 91-98
High-dose therapy with autologous or allogeneic transplantation as salvagetherapy for small cleaved cell lymphoma of follicular center cell origin
Authors: Stein, RS Greer, JP Goodman, S Kallianpur, A Ahmed, MS Wolff, SN
Citation: Rs. Stein et al., High-dose therapy with autologous or allogeneic transplantation as salvagetherapy for small cleaved cell lymphoma of follicular center cell origin, BONE MAR TR, 23(3), 1999, pp. 227-233
Factors correlated with progression-free survival after high-dose chemotherapy and hematopoietic stem cell transplantation for metastatic breast cancer
Authors: Rowlings, PA Williams, SF Antman, KH Fields, KK Fay, JW Reed, E Pelz, CJ Klein, JP Sobocinski, KA Kennedy, MJ Freytes, CO McCarthy, PL Herzig, RH Stadtmauer, EA Lazarus, HM Pecora, AL Bitran, JD Wolff, SN Gale, RP Armitage, JO Vaughan, WP Spitzer, G Horowitz, MM
Citation: Pa. Rowlings et al., Factors correlated with progression-free survival after high-dose chemotherapy and hematopoietic stem cell transplantation for metastatic breast cancer, J AM MED A, 282(14), 1999, pp. 1335-1343
Risultati: 1-13 |